TRANSLATION FROM WHO RECOMMENDATION TO IMPLEMENTATION INTO NATIONAL POLICY
|
|
- Derek Davis
- 5 years ago
- Views:
Transcription
1 TRANSLATION FROM WHO RECOMMENDATION TO IMPLEMENTATION INTO NATIONAL POLICY Ellis S 1, Musa A 2, Burza S 3, Alirol E 4, 5, Lima M A 3, Chappuis F 4, 5, Hailu A 6, Khalil E 2, Olobo J 7, Strub N 1, Wasunna M 1, 8, Sharma B 1, Balasegaram M 9, Author Affiliation: 1 Drugs for Neglected Diseases initiative, Switzerland; 2 Institute of Endemic Diseases, University of Khartoum, Sudan; 3 Médicos Sin Frontieras, Spain; Hôpitaux Universitaires de Genève, Switzerland; Médecins Sans Frontières, Switzerland, 6 Addis Ababa University School of Medicine, Ethiopia; 7 Makerere University, Uganda; 8 Kenya Medical Research Institute, Nairobi; 9 MSF Access Campaign Switzerland; Together for Impact World Leish 2013
2 2 Phase III Policy Implementation
3 India - Phase III Clinical trial efficacy 3 S Sundar study VL Combo study AmB SD Ampho B Ampho B AmB+M AmB+PM M+PM ITT Cure at M % % % % % % PP Cure at M % % % % % % Source:Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW: Single-dose liposomal amphotericin B for visceral leishmaniasis in India.. N Engl J Med Feb 11;362(6): Source: Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K et al: Comparison of shortcourse multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet 2011, 377(9764):
4 Clinical Trial Real life 4 Photo: DNDi, DNDi and sally Ellis Photo: DNDi, DNDi and Catherine Royce
5 India 5 All drugs are registered VL Treatments in use: Miltefosine monotherapy: 28 days conventional Amphotericin B: up to 30 days WHO Recommendation: No published data in Primary Health Care Setting Implementation plan conducted in PHC to evaluate treatments in a wider patient population in Bihar, India Assess the effectiveness Evaluate the safety profile Single dose AmB 10mg/kg on D 1 Combination: AmB 5mg/kg on D1 + MF D 2-8 MF + PM Day 1-10 AmB 5mg/kg on D1 + PM D 2-11 Assess if there are any important adverse outcomes in specific patient groups
6 6 Project Implementation with Partners Key Implementing Partners State Health Society Bihar: All the Doctors and supporting staff from Government, working at the District Hospital and PHCs. Rajendra Memorial Research Institute Patna, as site and training support Médecins Sans Frontières partners in Vaishali district LSHTM, ITM-Antwerp
7 Sites participating in VL PV Saran: District Hospital: Chhapra PHCs: Maraurah, Dariyapur, Baniyapur and Parsa Vaishali: District Hospital: Hajipur PHCs: Vaishali, Garaul, Mahua, Raghopur, and Mahnar
8 Project Design 8 Open label, prospective, non randomised, non comparative, multicentre, observational study assessing safety & effectiveness of new treatment PHC District Hospital/ Referral centre Sites PHCs in 2-3 districts in Bihar eg Vaishali, Saran 5+ PHC 5+ PHC 1-2 sites eg. District Hospital Referral Centres (special cases) Treatments Milt + PM for 10 d AmB (5) + Milt for 7d SDA Other VL treatments if SDA contraindicated Sample Size Safety: 2000 patients - 86% probability and 3000 patients - 95% probability that 1 ADR will be detected (expected incidence of 1/1000) Effectiveness: 300 patients treated, a failure risk of 5% could be estimated with at least 5% precision.
9 Key components of the project 9 Step 1- initial piloting Active monitoring & evaluation Surveillance register Safety (PV) Treatment Compliance Duration: 1-2 years Sites: 1-2 District hospitals and 10+ PHCs No. of patients: At least 1000 (300 per treatment) Follow up: 6 & 12 month follow up visit for efficacy Data review Step 2 consolidation/reporting Continue Surveillance register Continue PV Duration: 2-3 years Sites: Potential for implementation in other endemic areas by NCP and SHS. No. of patients: approximately monthly PUR. Long term reporting of AEs will be handed over to the NPP
10 Status - India 10 S.No Dates Training Venue Participants Dec 2011 MSF Team- study protocol & GCP, informed consent & pharmacovigilance Hajipur, Vaishali, Bihar Jan April 2012 Medical professional of PHCs, Allopathic doctors and AYUSH ANM Training school, Chappra, Saran, Bihar Sadar hospital, Hajipur, Vaishali May 2012 GCP Training Saran (24) & Vaishali (25) Recruitment Pilot Study Aug 12 Sep Oct Nov Dec Jan Feb Mar Apr Total SDA Total A+M Total P+M Total Recruited Classifications Number of Patients Paediatric patient < Severe disease 3 Severely Malnourished 4 TB +ve 1 Age less than 2 years 0 Pregnant 0 HIV +ve 9 PKDL 1
11 East Africa 11 WHO Recommendation Country Recommendation Kenya Sudan & Ethiopia Uganda Revised Guidelines launched SSG & PM Combination 17 Days Guidelines revised but not launched SSG Registration status PM Registration status Registered- Nov 08 Not registered Registered 2009 Registered - Feb 13 Submitted Registered Jan 2012 Project Objectives Monitor SSG&PM safety Identify additional risks that have not been reported during clinical studies To determine if ADR are increased in specific groups of patients Monitor the treatment failure rate Monitor any evidence in regional variation in terms of effectiveness & safety 11
12 Project Design 12 Sites Ethiopia Sudan Kenya Uganda Prospective Open label Multicentre Observational Pharmacovigilance Effectiveness Country Study Coordinator KEMRI Data Centre / TCC 1. Data review and collection 2. SAE 3. Supplies 1. Data Management 2. Coding 3. Report preparation Steering Committee 1. Safety review 2. Periodic update report
13 13 Participating Sites in SSG&PM Sudan 1. Kassab Hospital - IED 2. Prof El Hassan Centre for Tropical Disease, Doka 3. Tabarakallah - MSF 4. Um el Kehr MoH 5. Bazura MoH 6. Elhawata MOH Kenya 7. Kimalel - KEMRI 8. Kacheliba MSF, MoH/DNDi Ethiopia 9. Gondar University Hospital, 10. Abdurafi 11. Arba Minch Hospital Uganda 12. Amudat Hospital
14 Challenges to consider 15 Registration status required for implementation? EC and RA Approval Process Requirements for collecting additional data Clinical trial or not? Efficacy, safety or both? Special populations - young children, pregnant women etc. Patient registries eg pregnancy registry Feasibility of new treatments in resource limited setting? Revising & Implementing national treatment guidelines Status of National Pharmacovigilance program Collecting data in busy health centres / hospitals Training health care workers
15 ACKNOWLEDGEMENTS 16 All our patients East Africa India Site teams: Kassab Hospital and Prof El Hassan Centre for Tropical Disease, Doka, IED, Sudan; Tabarakallah MSF; Um el Kehr, Bazura, Elhawata, Ministry of Health, Sudan; Kimalel KEMRI; Kacheliba MSF, MoH/DNDi; Gondar University Hospital, Abdurafi, Arba Minch Hospital, Ethiopia; Amudat Hospital, Uganda; Team: Clelia Bardonneau,Robert Kimutai, Raymond Omollo, Godfrey Nyakaya, Peninah Menza, Michael Ochieng, Truphosa Omollo LEAP: Universities of Khartoum, Addis Ababa University, Gondar University, Makerere, Kenya Medical Research Institute; Ministries of Health of Kenya, Uganda, Ethiopia and Sudan, LSH&TM; MSF; I+ Solutions Donors: Médecins Sans Frontières/Doctors without Borders, International; Spanish Agency for International Development Cooperation (AECID), Spain; Swiss Agency for Development and Cooperation (SDC); Dutch Ministry of Foreign Affairs (DGIS), The Netherlands; Federal Ministry of Education & Research (BMBF) through KfW, Germany; Pro Victimis, Switzerland; Medicor Foundation, Liechenstein Site teams: Hajipur & Chhapra District Hospitals and Parsa, Marhaura, Dariyapur, Baniapur, Goraul, Mahnar, Mahua, Raghopur & Vaishalli PHCs Team: Nathalie Strub, Vishal Goyal, Abhijit Sharma, Pankaj Kumar, Muhammad Akram, Raj Kishore Rai, Anurag Singh Partners: Bihar State Health Society, MSF, Rajendra Memorial Research Institute, OWH/ PATH, WHO-TDR Donors: Bill & Melinda Gates Foundation; Department for International Development (DFID), UK; Médecins Sans Frontières/Doctors without Borders; Spanish Agency for International Development Cooperation (AECID); Swiss Agency for Development and Cooperation (SDC); Starr International Foundation, Switzerland; Other private foundations & private individual donors
Clinical mentoring a new approach for African VL
Clinical mentoring a new approach for African VL Margriet den Boer 1, Merce Herrero 2, Mounir Lado 3, Atia Atiaby 4, Duncan Ochol 3, Cherinet Adera 5, Jorge Alvar 6, Betgel Mekonen 5, Koert Ritmeijer 7
More informationNewsletter. Forewords. Focused Pharmacovigilance for Kala-azar in Nepal. Newsletter. Vol: 01 Issue: May, 2016
Newsletter Newsletter Focused Pharmacovigilance for Kala-azar in Nepal Focused Pharmacovigilance for Kala-azar in Nepal Vol: 01 Issue: May, 2016 Forewords Nepal government is implementing activities with
More informationOPERATIONAL RESEARCH. What, Why and How? Dr. Rony Zachariah MD, PhD Operational Centre Brussels MSF- Luxembourg
OPERATIONAL RESEARCH What, Why and How? Dr. Rony Zachariah MD, PhD Operational Centre Brussels MSF- Luxembourg rony.zachariah@brussels.msf.org What is operational research Search for knowledge on interventions,
More informationGrants given directly to researchers and developers: $1,849m (76%) Grants given to other intermediaries: $69m (2.8%)
76FINDINGS - FUNDING FLOWS FUNDING FLOWS Organisations can invest in neglected disease R&D in two main ways: by funding their own in-house research (internal investment, also referred to as intramural
More informationCONSORT guidelines for reporting abstracts of randomized trials. Sally Hopewell
CONSORT guidelines for reporting abstracts of randomized trials Sally Hopewell EQUATOR Seminar 3 October 2011 Centre for Statistics in Medicine, University of Oxford, UK I recently met a physician from
More informationHow do health care providers deal with kala-azar in the Indian subcontinent?
Indian J Med Res 134, September 211, pp 349-355 How do health care providers deal with kala-azar in the Indian subcontinent? Narendra Kumar 1,*, Shri Prakash Singh 2, Dinesh Mondal 3, Anand Joshi 4, Pradeep
More information$3,203m 73% Global investment in. neglected disease R&D. $420m Funding to PDPs
94FINDINGS - FUNDING FLOWS FUNDING FLOWS Organisations can invest in neglected disease R&D in two main ways: by funding their own in-house research (internal investment, also referred to as intramural
More informationOverview of Draft Pharmacovigilance Protocol
Overview of Draft Pharmacovigilance Protocol Identifying ADRs in Africa Special Challenges Malaria - pan-systemic clinical features Life-threatening condition Real-world trial AS/SP and co-artem safety
More informationRequest for Proposal
Request for Proposal Electronic Data capture and Data Management activities to support the conduction of a phase 2 trial in Chagas Disease Dated: 29 June 2015 Page 1 TABLE OF CONTENTS 1. PURPOSE... 3 2.
More informationPlease place your phone line on mute.
We will begin the MaRISS Coordinator Call shortly Please place your phone line on mute. 8/26/2016 2 Overview Missing data Correct dates on Baseline NIHSS Form 24 hour window for consent CRF Forms What
More informationOverview of a new study to assess the impact of hospice led interventions on acute use. Jonathan Ellis, Director of Policy & Advocacy
Overview of a new study to assess the impact of hospice led interventions on acute use Jonathan Ellis, Director of Policy & Advocacy The problem Almost 600,000 people die each year Half will die in a hospital
More informationEACCR Reciprocal Monitoring Annet Nanvubya & Elizabeth Ayuo
EACCR Reciprocal Monitoring Annet Nanvubya & Elizabeth Ayuo 14 th February 2013 GHT workshop in Entebbe Monitoring Definition (1) The act of overseeing the progress of a clinical trial, and of ensuring
More information(4-years project - funded by a grant from EU FP7 ) 10/11/2017 2
10/11/2017 1 Linking communities and facilities to improve maternal and newborn health: Lessons from the Expanded Quality Management Using Information Power trial in Uganda and Tanzania (4-years project
More informationCorporate Induction: Part 2
Corporate Induction: Part 2 Identification of preventable Adverse Drug Reactions from a regulatory perspective March 1 st 2013, EMA Workshop on Medication Errors Presented by Almath Spooner, Pharmacovigilance
More informationEMSCO. The European MDS studies coordination office. Supporting Clinical Research, Education and Consulting in the field of MDS across Europe
EMSCO The European MDS studies coordination office Supporting Clinical Research, Education and Consulting in the field of MDS across Europe FISM Torino, 1. Apr. 2014 MDS Clinical Trials in Europe 2014
More informationEuropean Patients Academy (EUPATI) Update
European Patients Academy (EUPATI) Update EMA meeting with patient/consumer organisations 11 Dec 2013 Maria Mavris EURORDIS // EUPATI WP4 Co-Lead For patient-centric medicines R&D and to contribute to
More informationGood Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA
Good Pharmacovigilance Practice Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA Content ADR Reporting Definition & Increased scope Transition arrangements
More informationTHE AFRICAN MEDICINES REGULATORY HARMONIZATION (AMRH) INITIATIVE Accomplishments, Challenges and Path Forward
THE AFRICAN MEDICINES REGULATORY HARMONIZATION (AMRH) INITIATIVE Accomplishments, Challenges and Path Forward THE AFRICAN MEDICINES REGULATORY HARMONIZATION (AMRH) INITIATIVE Accomplishments, Challenges
More informationSituation Analysis Tool
Situation Analysis Tool Developed by the Programme for Improving Mental Health CarE PRogramme for Improving Mental health care (PRIME) is a Research Programme Consortium (RPC) led by the Centre for Public
More informationAmbulatory Care Day 1 for Multidrug Resistant Tuberculosis
Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology
More informationRBF in Zimbabwe Results & Lessons from Mid-term Review. Ronald Mutasa, Task Team Leader, World Bank May 7, 2013
RBF in Zimbabwe Results & Lessons from Mid-term Review Ronald Mutasa, Task Team Leader, World Bank May 7, 2013 Outline Country Context Technical Design Implementation Timeline Midterm Review Results Evaluation
More informationVisceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India
Boettcher et al. BMC Infectious Diseases (2015) 15:43 DOI 10.1186/s12879-015-0767-5 RESEARCH ARTICLE Open Access Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response
More informationChange Management at Orbost Regional Health
Change Management at Orbost Regional Health Our change management journey 1 Medication Change System Meds at Beds 2 The slightly exaggerated before process 3 Project Goals The purpose of the Meds at Beds
More informationPharmacovigilance in Kenya
Pharmacovigilance in Kenya Dr. Dorine Kagai (NASCOP) Mr. George Muthuri (PPB) Ministry of Medical Services 23 nd November, 2009 ARV PV TRAINING TZ ART program. Over 300,000 patients on ARVs: Over 60% female
More informationPAED-Net the German Network
PAED-Net the German Network Clinical Research in Paediatrics 2nd Symposium of the Swiss Clinical Trial Organisation 9th June, 2011, Basel Prof. Dr. Fred Zepp Department of Paediatrics University Medical
More informationProgress in implementation of prevalence surveys in the 21 global focus countries: an overview of achievements, challenges and next steps
Progress in implementation of prevalence surveys in the 21 global focus countries: an overview of achievements, challenges and next steps Ikushi Onozaki WHO/STB/TME Team Leader: TB Prevalence Survey Global
More informationFrank Fowlie. Office of the Ombudsman. Remarks at Marrakesh Public Forum. June 28, Check against delivery
Frank Fowlie Office of the Ombudsman Remarks at Marrakesh Public Forum June 8, 006 Check against delivery Frank Fowlie 6/8/006 Check against Delivery Wellington Remarks 5:7: AM Mr. Chairman, Vint Cerf,
More informationCLIC Clinical Investigator (And Site Staff) Certification
CLIC Clinical Investigator (And Site Staff) Certification CLIC Level 1: 23-24 March 2015 CLIC Level 2: 25-27 March 2015 Cape Town (Venue to be confirmed) C PD points L e v e l 1 : 1 4 G e n e r a l, 2
More informationFP7 Post-Grant Open Access Pilot: Sixth Progress Report One Year into the Initiative
FP7 Post-Grant Open Access Pilot: Sixth Progress Report One Year into the Initiative This is the sixth progress report for the FP7 Post-Grant Open Access Pilot one year since its launch on May 30 th, 2015.
More informationCorporate Services Employment Report: January Employment by Staff Group. Jan 2018 (Jan 2017 figure: 1,462) Overall 1,
Corporate Services Employment Report: January Employment by Staff Group Jan (Jan 20 figure: 1,462) Jan % Overall 1,520 +58 +4.0% 8 Management (VIII+) 403 +52 4.8% Clerical & Supervisory (III to VII) 907
More informationSPLASH SANITATION RESEARCH CALL AND PROGRAMME
ERAC-CT-2006-036268 SPLASH SANITATION RESEARCH CALL AND PROGRAMME Consolidated report from the development of the research call to the implementation of the research programme Consolidated Deliverables
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationThe New Funding Model
The New Funding Model Collaboration among partners 2 Content 1 Introducing the new funding model & the transition 2 Preparations for the full roll-out to standard applicants 3 Principles of the new funding
More informationEmergency Plan of Action (EPoA)
Emergency Plan of Action (EPoA) Guinea Bissau: Ebola Virus Preparedness DREF Date of Issue: 4 May, 2015 Operation n MDRGW002 Glide n EP-2014-000039-GNB Operation start date: 8 October, 2014 Operation end
More informationCURRICULUM VITAE. 23 December 1968, Varna, Bulgaria
CURRICULUM VITAE NAME: Milen Nikolaev Vrabevski, MD DATE/PLACE OF BIRTH: 23 December 1968, Varna, Bulgaria CONTACT DETAILS: South Side Business Centre 38, Maystor Aleksi Rilets Str., 5th fl. Res. Distr.
More informationPatient Registries Initiative Background, Achievements, Next steps
Patient Registries Initiative Background, Achievements, Next steps 21 November 2017 ENCePP Plenary meeting Presented by Xavier Kurz, Surveillance & Epidemiology Service, European Medicines Agency An agency
More informationSTRENGTHENING ANTIRETROVIRAL TREATMENT FOR WOMEN AND CHILDREN IN MATERNAL, NEONATAL, AND CHILD HEALTH SERVICES
ZIMBABWE PROGRAM BRIEF NO. 4 PVO10/2009 2015 STRENGTHENING ANTIRETROVIRAL TREATMENT FOR WOMEN AND CHILDREN IN MATERNAL, NEONATAL, AND CHILD HEALTH SERVICES Experiences from the Elizabeth Glaser Pediatric
More informationIMCI. information. Integrated Management of Childhood Illness: Global status of implementation. June Overview
WHO/CHS/CAH/98.1B REV.1 1999 ORIGINAL: ENGLISH DISTR.: GENERAL IMCI information INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS (IMCI) DEPARTMENT OF CHILD AND ADOLESCENT HEALTH AND DEVELOPMENT (CAH) HEALTH
More informationPower. Jan 04 Plan. Goal June 04: 6,000 MW Production and Transmission. Data as of 26 Feb UNCLASSIFIED
6000 5000 4000 3000 2000 3,948 3,582 3,427 3,758 4,134 Goal June 04: 6,000 MW Production and Transmission Power Jan 04 Plan Oct 03 Nov 03 Dec 03 Jan 04 Feb 04 Mar 04 Apr 04 May 04 Jun 04 Electrical Generation
More informationEDCTP2 - Opportunities for clinical research on poverty-related diseases in sub-saharan Africa.
EDCTP2 - Opportunities for clinical research on poverty-related diseases in sub-saharan Africa. Info Day, Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing 8 July 2016, Brussels
More informationPharmacists' involvement in clinical trials and ethical committees
19th Congress of the European Associat Barcelona, Spain, 26-28 March 2014 Barcelona, Spain, 26-28 19 th CONGRESS OF THE EUROPEAN ASSOCIATION OF HOSPITAL PHARMACISTS Pharmacists' involvement in clinical
More informationSafety in Mental Health Collaborative
NHS Tayside Safety in Mental Health Collaborative Improving Safety in Mental Health Programme Aims supported by an Improvement Advisor: Dr Noeleen Devaney Support 4 UK organisations to: reduce harm improving
More informationApplication of Implementation Science to TB Evaluation: A Case Study from Uganda
Application of Implementation Science to TB Evaluation: A Case Study from Uganda Adithya Cattamanchi, MD, MAS acattamanchi@medsfgh.ucsf.edu Advanced TB Diagnostics Research Course July 9, 2014 Implementation
More informationWellcome Trust Strategy for Strengthening Health Research Capacity in Africa
Wellcome Trust Strategy for Strengthening Health Research Capacity in Africa Medical Education Partnership Annual Symposium 2011 7 th March 2011 Dr Val Snewin Internal Activities Manager International
More informationSTRENGTHENING NATIONAL IMPLEMENTATION
REGIONAL WORKSHOP FOR AFRICA PREPARING FOR THE EIGHTH REVIEW CONFERENCE OF THE BIOLOGICAL WEAPONS CONFERENCE Addis Ababa, Ethiopia, 13 14 September 2016 STRENGTHENING NATIONAL IMPLEMENTATION Austin Ochieng
More informationSafeguarding public health. The New PV Legislation its Impact on PV & MI
Safeguarding public health The New PV Legislation its Impact on PV & MI Sarah Vaughan - MHRA PIPA 2013 Manager s Meeting 13 th February 2013 Content Scope of change Key areas - ADR reporting - DDPS to
More informationImplementing Differentiated Services Delivery: Differentiated Monitoring & Evaluation
Implementing Differentiated Services Delivery: Differentiated Monitoring & Evaluation William Reidy, PhD ICAP at Columbia University 9th IAS Conference on HIV Science Paris, France July 23, 2017 Background/Context
More informationPatient Centricity In Pharmacovigilance:
Patient Centricity In Pharmacovigilance: New Directions, New Horizons Background The importance of Pharmacovigilance (PV) as a science and its role in effective patient care in clinical practice and public
More informationSTATISTICAL PRESS NOTICE MONTHLY CRITICAL CARE BEDS AND CANCELLED URGENT OPERATIONS DATA, ENGLAND March 2018
STATISTICAL PRESS NOTICE MONTHLY CRITICAL CARE BEDS AND CANCELLED URGENT OPERATIONS DATA, ENGLAND March 2018 Main Findings March 2018: Critical Care Beds There were 4,064 adult critical care beds available
More informationNew gtld Program Update. 12 March 2012
New gtld Program Update 12 March 2012 Agenda Already happening Application processing status Communications Applicant support Under discussion Batching TLD acceptance Defensive applications What happens
More informationPublic health, innovation and intellectual property: global strategy and plan of action
EXECUTIVE BOARD EB126/6 126th Session 3 December 2009 Provisional agenda item 4.3 Public health, innovation and intellectual property: global strategy and plan of action Report by the Secretariat 1. The
More informationEnlisted Professional Military Education FY 18 Academic Calendar. Table of Contents COLLEGE OF DISTANCE EDUCATION AND TRAINING (CDET):
Enlisted Professional Military Education FY 18 Academic Calendar Table of Contents STAFF NON-COMMISSIONED OFFICER ACADEMIES: SNCO Academy Quantico SNCO Academy Camp Pendleton SNCO Academy Camp Lejeune
More informationRoundtable on health systems strengthening in fragile settings
Roundtable on health systems strengthening in fragile settings 12 February 2015, 10h 16.15h, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp (Room C, main building) Organized jointly
More informationCompliance Division Staff Report
Compliance Division Staff Report Polygraph Advisory Board Meeting Tuesday, September 26, 2017 Public Outreach Compliance Division routinely attends annual industry meetings held by TALEPI (Texas Association
More informationHealth Publications 2009 from TSO
Health Publications 2009 from TSO British Pharmacopoeia The authoritative collection of standards for UK medicines The British Pharmacopoeia 2010 British Pharmacopoeia Commission The British Pharmacopoeia
More informationIs dedication all you need to deliver to time and target in a multicentre study? Lessons learned from the Prevention of Delirium (POD) study
Is dedication all you need to deliver to time and target in a multicentre study? Lessons learned from the Prevention of Delirium (POD) study Suzanne Hartley, John Green, Amanda Farrin, Marie Fletcher,
More information4.2 Reducing Rates of Moderate to Severe Adverse Events
4.2 Reducing Rates of Moderate to Severe Adverse Events Voluntary medical male circumcision is a surgical HIV prevention intervention, and it is therefore important that it is safe for clients and that
More informationROLLING TRAINING CALENDAR
381 Rossouw Street Murrayfield 0184 Pretoria Gauteng South Africa Tel: +27 (0)12 803-6223 /-5955 /-1039 Fax: +27 (0)12 803-3575 www.mra-regulatory.com ROLLING TRAINING CALENDAR 2017 2018 SHORT COURSES
More informationExperiences of using routinely collected medical data in a cardiovascular safety trial?
Experiences of using routinely collected medical data in a cardiovascular safety trial? Ian Ford Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit Issues in clinical trials Study feasibility
More informationInfluence of Patient Flow on Quality Care
Influence of Patient Flow on Quality Care Patients Waiting on Trolleys for an Inpatient Bed Patients who are Medically Fit to be discharged and cared for at Home with Support or in a Nursing Home or District
More informationInitiation and scale-up of MDR-TB care in Ethiopia
Initiation and scale-up of MDR-TB care in Ethiopia Anne Goldfeld Global Health Committee Immune Disease Institute Harvard Medical School Harvard School of Public Health July 30, 2012 IOM Forum Washington
More informationFollow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
EXECUTIVE BOARD EB138/39 138th session 18 December 2015 Provisional agenda item 10.3 Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
More informationDeveloping Epidemiology Workforce Through FELTP as Critical Needs for Networks : Lessons Learned and Next Steps. Dr Patrick M Nguku
Developing Epidemiology Workforce Through FELTP as Critical Needs for Networks : Lessons Learned and Next Steps Dr Patrick M Nguku 1 Field Epidemiology & Laboratory Training Program (FELTP) Closely supervised
More informationGroup Professionals Concept. Robbin Brugman MD Group Professionals Concept
Group Professionals Concept Robbin Brugman MD Group Professionals Concept professionals important aspect in strategic roadmap * * 2009 revenue professionals 2.7 bln. 2 Randstad among leading players in
More informationImproving health care Nigel Livesley MD, MPH
Improving health care Nigel Livesley MD, MPH Regional Director, South Asia USAID ASSIST Project University Research Co., LLC (URC) 1 50% of women attending an ANC clinic did not get their BP and Hb measured
More informationBETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS
A2 BETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS March 2012 A3 BETTER REGULATION OF MEDICINES INITIATIVE (BROMI) FIFTH REPORT ON PROGRESS Chief Executive s foreword In January
More informationCurriculum Vitae Pieter-Paul Gunneweg, MSc, BSc, BA. Pieter-Paul Gunneweg (1956, the Netherlands)
Bio Data and Contact Name Profession Contact Skype Linked-in Pieter-Paul Gunneweg (1956, the Netherlands) imprint.gunneweg@gmail.com ppmgunneweg Pieter-Paul (Peter) Gunneweg Summary Function Expertise
More informationUpdate from ECHA. REACH Implementation Workshop X. 13 December Laurence Hoffstadt ECHA Substance Identification & Data Sharing
Update from ECHA REACH Implementation Workshop X 13 December 2011 Laurence Hoffstadt ECHA Substance Identification & Data Sharing Overview Update registrations/ dissemination Summary Analysis 2010- substances
More informationCURRICULUM VITAE. Education background 2009 to 2013 University of Nairobi Master of Medicine in General Surgery
CURRICULUM VITAE Personal particulars Name: Dr Nyamohanga M. Patrick Date of birth: 25 th Feb 1979 Sex: Marital status: Nationality: Male Married Kenyan Permanent address: P.O. Box 20154-00100, Mobile
More informationWhat happened before MMC?
Modernising Medical Careers: Foundation Programme Application Process Dr (Insert Name) (insert title) What happened before MMC? PRHO (F1) and SHO (F2) Applications all year round Multiple applications
More informationLinking Partners Across Funding and Technical Stream: The Ethiopia Experience with CORE Group Polio Project
Linking Partners Across Funding and Technical Stream: The Ethiopia Experience with CORE Group Polio Project Filimona Bisrat (MD, MPH) CGPP Secretariat Ethiopia Director and Senior Regional Technical Adviser
More informationSummary of Country Reports Current Status of 12 FNCA Member States
Summary of Country Reports Current Status of 12 FNCA Member States Naoki Kobayashi Integrated Support Center for Nuclear Nonproliferation and Nuclear Security(ISCN) Japan Atomic Energy Agency(JAEA) December
More informationEvaluating adverse events from patient support and market research programs: proposed best practices and regulatory changes
Evaluating adverse events from patient support and market research programs: proposed best practices and regulatory changes 2 nd Adverse Event Reporting and Safety Strategies Summit December 8-9, 2015
More informationInfluence of Patient Flow on Quality Care
Influence of Patient Flow on Quality Care Patients Waiting on Trolleys for an Inpatient Bed Patients who are Medically Fit to be discharged and cared for at Home with Support or in a Nursing Home or District
More informationEmployment Record: Population Council, Department for International Development, Nairobi, Humanitarian Aid Department Oxfam
CHARLOTTE E WARREN (2009) Population Council P.O. Box 17643 00500 Nairobi, KENYA Tel: +254 20 2713480 Fax: +254 20 2713479 Email: cwarren@popcouncil.org Expertise: Reproductive Health, Family Planning,
More informationJANUARY 2018 (21 work days) FEBRUARY 2018 (19 work days)
AND CORRESPONDING DATES FOR JANUARY AND FEBRUARY 2018 JANUARY 2018 ( work days) Deadline* 12-27 12-28 12-29 1-2 1-3 1-4 1-5 1-8 1-9 1-10 Benefit Hold ** 12-28 12-29 1-2 1-3 1-4 1-5 1-8 1-9 1-10 1-11 Mailing
More informationWHO Pharmacovigilance Indicators. Dr. Nitin Gaikwad Co-coordinator, ADR Monitoring Center, PvPI Additional Professor, Pharmacology AIIMS Raipur
WHO Pharmacovigilance Indicators Dr. Nitin Gaikwad Co-coordinator, ADR Monitoring Center, PvPI Additional Professor, Pharmacology AIIMS Raipur Scope of presentation Sensitization of Coordinators, Co-coordinators,
More informationSponsored by Supported by Presented by
Sponsored by Supported by Presented by ABOUT RIO NEGÓCIOS Business Development Agency of Rio de Janeiro Investment Promotion Facilitation PORTFOLIOS ENERGY CREATIVE ECONOMY INFRASTRUCTURE FINANCIAL SERVICES
More informationPREDNOS 2 Newsletter. randomised controlled trial (RCT).
PREDNOS 2 Newsletter Issue 18 December 2017 Full Title: Short course daily prednisolone therapy at the time of upper respiratory tract infection (URTI) in children with relapsing steroid sensitive nephrotic
More informationClub Phase I & AGAH 3 rd Joint Annual Meeting
Club Phase I & AGAH 3 rd Joint Annual Meeting Session 3:Managing the risk of Phase I trials Accreditation of Phase I Units in the UK Dr Jorg Taubel MD FFPM Lyon, 29 April 2009 Changes to the regulatory
More informationPalestinian National Authority Ministry of Health. Palestinian Health Status
Palestinian National Authority Ministry of Health Palestinian Health Status Acknowledgement WHO efforts for organizing this vital meeting under the critical situations Palestine is facing. WHO, UNICEF
More informationDraft Bidding Docs and SPN. Bank s NO to bidding docs. Invitat. To Bidder b Goods
re Authorized Procurement Plan Initial approval August 2009 1st revision December 2009 2nd revision May 2011 Bid No: Description Type Method Actual costs Draft Bidding Docs and SPN Bank s NO to bidding
More informationLinking Researchers with their Research: Persistent identifiers, registries, and interoperability standards
Linking Researchers with their Research: Persistent identifiers, registries, and interoperability standards 12 November 2013 Rebecca Bryant, PhD Director of Community, ORCID R.Bryant@orcid.org http://orcid.org/0000-0002-2753-3881
More informationUnemployment and Changes in the Rate of Unemployment
Unemployment and Changes in the Rate of Unemployment 1. Introduction Information is the key to marketing success. The more relevant information you have about people the more successful you are likely
More informationC.O.R.E. MISSION STATEMENT
C.O.R.E. MISSION STATEMENT Comprehensive Opiate Recovery Experience RECOVERY WITH RESPECT Improving the lives of individuals through comprehensive opiate replacement services C.O.R.E. MEDICAL CLINIC IS
More informationCURRILUCULUM VITAE. 1. Clinical Research Training Course (2010) 2. Cervical Cancer Screening (2008)
CURRILUCULUM VITAE PROFILE Charity Njambi Ndwiga Po Box 53647 Code 00200 Nairobi 2725705-8 (Office) Mobile 0722395641 A Bachelor Degree/Registered Nurse Midwife by profession, Charity is a winner of 1997
More informationWHO role in the introduction of new TB drugs and regimens: (2) Supporting introduction in countries
WHO role in the introduction of new TB drugs and regimens: (2) Supporting introduction in countries GDI/GLI Meeting Session 3 Geneva 27 th April 2015 Christian Lienhardt Global TB Programme World Health
More informationNOTE BY THE DIRECTOR-GENERAL THE PROGRAMME TO STRENGTHEN COOPERATION WITH AFRICA ON THE CHEMICAL WEAPONS CONVENTION
OPCW Executive Council Eighty-Ninth Session EC-89/DG.14 9 12 October 2018 5 September 2018 Original: ENGLISH NOTE BY THE DIRECTOR-GENERAL THE PROGRAMME TO STRENGTHEN COOPERATION WITH AFRICA ON THE CHEMICAL
More informationPROJECTS. FOR THE MONTHS OF December 2017 and January 2018
PROJECTS FOR THE MONTHS OF December 2017 and January 2018 Foundation Marketing 2017 Foundation Websites - Web Usage Report (Jan - Dec 2017) * ** ** ** Column R Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
More informationBOROUGH OF ROSELLE PUBLIC NOTICE ANNUAL NOTICE OF CALENDAR YEAR 2018 WORKSHOP SESSIONS, PRE-AGENDA MEETINGS AND REGULAR MEETINGS
BOROUGH OF ROSELLE PUBLIC NOTICE ANNUAL NOTICE OF CALENDAR YEAR 2018 WORKSHOP SESSIONS, PRE-AGENDA MEETINGS AND REGULAR MEETINGS BE IT RESOLVED, by the Mayor and Borough Council of the Borough of Roselle,
More informationAfrica Call Projects and Clusters Analysis of Potential Funding and Implementing Programmes
Africa Call Projects and Clusters Analysis of Potential Funding and Implementing Programmes Deliverable 8.2.1 January 2013 This document has been prepared by: A Network for the Coordination and Advancement
More informationReal World Evidence in Europe
Real World Evidence in Europe Jessamy Baird, RWE Director Madrid, 20 th October 2014. BEFORE I BEGIN; DISCLAIMERS: Dual perspective: Pharmaceutical: I work for Lilly, but this presentation represents my
More informationTranslating Evidence to Safer Care
Translating Evidence to Safer Care Patient Safety Research Introductory Course Session 7 Albert W Wu, MD, MPH Former Senior Adviser, WHO Professor of Health Policy & Management, Johns Hopkins Bloomberg
More informationHealth Manpower Planning
Health Manpower and Management 10.5005/jp-journals-10055-0013 1 Rajoo S Chhina, 2 Rajdeep S Chhina, 3 Ananat Sidhu, 4 Amit Bansal ABSTRACT Manpower is the most crucial resource toward delivery of health
More informationUnlocking Pre Actions Taken and Planned Activities in Relation to the UNFCCC Technical Examination Process. Jukka Uosukainen Director
Unlocking Pre-2020 Update by Mr. Fred Onduri Ambition: CTCN Advisory CTCN Board Chair Actions Taken and Planned Activities in Relation to the UNFCCC Technical Examination Process Jukka Uosukainen Director
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationSuggestions for Modification of the Clinical Trials Directive ELN Annual Meeting 01 February 2011
Suggestions for Modification of the Clinical Trials Directive ELN Annual Meeting 01 February 2011 European Medical Research Councils Dr Kirsten Steinhausen 1 ESF Member Organisations ESF is an independent
More informationPharmaceutical Services Report to Joint Conference Committee September 2010
Pharmaceutical Services Report to Joint Conference Committee September 21 Background: Pharmaceutical Services staffing has increased by 31 FTE from 26 due to program changes and to comply with regulatory
More informationInternational trend on medical device regulatory convergence
International trend on medical device regulatory convergence Mari Shirotani, Ph.D. Division Director, Office of International Programs Pharmaceuticals and Medical Devices Agency (PMDA) 1st December, 2017
More informationPublic Disclosure Copy
Public Disclosure Authorized AFRICA Ethiopia Finance & Markets Global Practice IBRD/IDA Investment Project Financing FY 2016 Seq No: 4 ARCHIVED on 06-Dec-2017 ISR30229 Implementing Agencies: National Bank
More information